159 related articles for article (PubMed ID: 35468990)
1. Human herpesvirus 8 infection is associated with prostate cancer among IFNL4-ΔG carriers.
Jenkins FJ; Minas TZ; Tang W; Dorsey TH; Ambs S
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):338-346. PubMed ID: 35468990
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
3.
Minas TZ; Tang W; Smith CJ; Onabajo OO; Obajemu A; Dorsey TH; Jordan SV; Obadi OM; Ryan BM; Prokunina-Olsson L; Loffredo CA; Ambs S
Commun Biol; 2018; 1():191. PubMed ID: 30456312
[TBL] [Abstract][Full Text] [Related]
4.
Tang W; Wallace TA; Yi M; Magi-Galluzzi C; Dorsey TH; Onabajo OO; Obajemu A; Jordan SV; Loffredo CA; Stephens RM; Silverman RH; Stark GR; Klein EA; Prokunina-Olsson L; Ambs S
Clin Cancer Res; 2018 Nov; 24(21):5471-5481. PubMed ID: 30012562
[No Abstract] [Full Text] [Related]
5. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR
PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156
[TBL] [Abstract][Full Text] [Related]
6. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
7. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
Aka PV; Kuniholm MH; Pfeiffer RM; Wang AS; Tang W; Chen S; Astemborski J; Plankey M; Villacres MC; Peters MG; Desai S; Seaberg EC; Edlin BR; Strickler HD; Thomas DL; Prokunina-Olsson L; Sharp GB; O'Brien TR
J Infect Dis; 2014 Feb; 209(3):350-4. PubMed ID: 23956438
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
[TBL] [Abstract][Full Text] [Related]
9. A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection.
Jaimes-Bernal C; Rallón N; Benito JM; Omar M; Gómez-Vidal MA; Márquez FJ; Sánchez-Arcas B; Trujillo M; Royo JL; Saulle I; Biasin M; Rivero-Juárez A; Caruz A
J Infect Dis; 2019 Feb; 219(5):772-776. PubMed ID: 30289470
[TBL] [Abstract][Full Text] [Related]
10. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study.
Tanriver U; Emmerich F; Hummel JF; Jänigen B; Panning M; Arnold F; Tanriver Y
Clin Transplant; 2022 Jul; 36(7):e14663. PubMed ID: 35368114
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
12. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
[TBL] [Abstract][Full Text] [Related]
13. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
[TBL] [Abstract][Full Text] [Related]
14. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
Wu R; Chi X; Wang X; Sun H; Lv J; Gao X; Yu G; Kong F; Xu H; Hua R; Jiang J; Sun B; Zhong J; Pan Y; Niu J
Infect Genet Evol; 2016 Apr; 39():132-140. PubMed ID: 26820907
[TBL] [Abstract][Full Text] [Related]
15. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
[TBL] [Abstract][Full Text] [Related]
16. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
[TBL] [Abstract][Full Text] [Related]
17. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
[TBL] [Abstract][Full Text] [Related]
18.
Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
[TBL] [Abstract][Full Text] [Related]
19. Elevated seroprevalence of human herpesvirus 8 among men with prostate cancer.
Hoffman LJ; Bunker CH; Pellett PE; Trump DL; Patrick AL; Dollard SC; Keenan HA; Jenkins FJ
J Infect Dis; 2004 Jan; 189(1):15-20. PubMed ID: 14702148
[TBL] [Abstract][Full Text] [Related]
20. IFNL4: Notable variants and associated phenotypes
Fang MZ; Jackson SS; O'Brien TR
Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
